Kamada (KMDA) Beginning Cash Balance (2015 - 2025)
Kamada (KMDA) posted quarterly Beginning Cash Balance of $72.0 million for Q4 2025, little changed year-on-year from $72.0 million in Q4 2024, and little changed on a QoQ basis from $72.0 million in Q4 2024.
Kamada (KMDA) Beginning Cash Balance (2015 - 2025) Analysis & Trends
Kamada (KMDA) has reported Beginning Cash Balance for 11 consecutive years, with $72.0 million the latest figure, recorded in Q4 2025.
- Quarterly Beginning Cash Balance changed 0.01% year-over-year to $72.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $215.2 million (up 0.84% YoY) and the FY2025 annual result came in at $78.4 million, up 40.97% from the prior year.
- Beginning Cash Balance held at $72.0 million in Q4 2025 per KMDA's latest filing, from $72.0 million in the prior quarter.
- Over the last five years, Beginning Cash Balance for KMDA reached as high as $72.0 million in Q4 2024 and fell as low as $18.6 million in Q1 2022.
- A 5-year average of $57.1 million and a median of $70.2 million in 2021 frame the typical range for Beginning Cash Balance.
- Annual changes were most pronounced in 2021 — Beginning Cash Balance soared 64.54% — and 2022, when it plunged 73.52%.
- Year by year, Beginning Cash Balance stood at $70.2 million in 2021, then tumbled by 73.52% to $18.6 million in 2022, then soared by 183.01% to $52.6 million in 2023, then soared by 36.88% to $72.0 million in 2024, then declined by 0.01% to $72.0 million in 2025.
- According to Business Quant data, Beginning Cash Balance over the past three periods registered $72.0 million, $72.0 million, and $52.6 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 72.00 Mn |
| Dec 31, 2025 | 72.00 Mn |
| Dec 31, 2024 | 72.00 Mn |
| Dec 31, 2024 | 72.00 Mn |
| Dec 31, 2023 | 52.60 Mn |
| Dec 31, 2023 | 52.60 Mn |
| Mar 31, 2022 | 18.59 Mn |
| Mar 31, 2022 | 18.59 Mn |
| Mar 31, 2021 | 70.20 Mn |
| Mar 31, 2021 | 70.20 Mn |
| Mar 31, 2020 | 42.66 Mn |
| Mar 31, 2020 | 42.66 Mn |
| Mar 31, 2019 | 18.09 Mn |
| Mar 31, 2019 | 18.09 Mn |
| Jun 30, 2018 | 17.50 Mn |
| Jun 30, 2018 | 17.50 Mn |
| Mar 31, 2018 | 12.68 Mn |
| Mar 31, 2018 | 12.68 Mn |
| Dec 31, 2017 | 12.16 Mn |
| Dec 31, 2017 | 12.16 Mn |